We hear you! Your pharmacy workplace is stressed and stretched. You have rapidly growing concerns for patient safety. Still, you are there—every day—to care for your patients despite conditions that seem to be working against you.

WASHINGTON, DC – Pharmacy organizations are applauding a decision by the Eighth Circuit of the U.S. Court of Appeals today that supports North Dakota's right to regulate pharmacy benefit managers. The case, Pharmaceutical Care Management Association v. Wehbi, is the first to consider at the federal appellate level the scope of the U.S. Supreme Court's unanimous decision last year in Rutledge v. PCMA, which upheld an Arkansas state law regulating the abusive practices of PBMs.

The Institute for Safe Medication Practices (ISMP) is alerting health care providers about potential confusion over new alternative packaging for casirivimab and imdevimab. These monoclonal antibodies, administered together as REGEN-COV, are used for treating COVID-19. ISMP recently received multiple reports about these types of errors.

According to CDC, people most often cite pain management as their reason for using medical cannabis in the United States. But according to a new clinical practice guideline published by Busse and colleagues in the September 2021 issue of BMJ, there is weak evidence to support the use of non-inhaled medical cannabis or cannabinoids for chronic pain. The recommendation is based on a robust analysis of results from 32 randomized controlled clinical trials.